olivlawolivlaw

olivLaw · European equity research

Aedifica AED.BR

Belgium · Euronext Brussels · Vertical: Listed companies from Belgium

65.10EUR−0.31% · 1 dayClose 05 Nov 2026

Aedifica is a Belgian investor in healthcare real estate, with a portfolio of 617 care sites in eight European countries, operated by more than 140 operator groups. The company remains relevant because of structural demand created by an ageing population, though higher financing costs and slower transaction markets in 2023 were a challenge.

At the close of 05 Nov 2026, Aedifica (AED.BR) stock was 65.10 EUR (−0.31% on the day), with market capitalisation 2.9 bn EUR, P/E 116.2 on diluted EPS of 0.56 EUR over the last 12 months, dividend yield 4.07%, beta 0.27, 52-week range 60.55–79.25 EUR.

Data as of · AI analysis dated · Source: ESEF annual reports and closing prices, computed by olivLaw.

Market cap
2.9 bn EUR
shares as of 31 Dec 2023
P/E (TTM)
116.2
Diluted EPS TTM 0.56 · TTM to 31 Dec 2023
E/P (TTM)
0.86%
TTM to 31 Dec 2023
Dividend yield
4.07%
DPS 12m 2.65
Beta (2y)
0.27
Volatility (1y) 18%
52-week range
60.5579.25

Price history

Loading chart…

Technical reading

RSI (14)
62.5
strong (55–70)
Bollinger (20, 2)
60.93 – 65.34
in the upper half of the band · %B 0.95 · band width 7.0%
SMA 50 / 200
64.37 / 69.69
mixed trend
MACD (12, 26, 9)
0.21 / -0.19
MACD above signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyEURO STOXX 50vs EURO STOXX 50Vertical median
1 month+4.7%−0.6%+5.4 pp—
3 months−6.1%−4.2%−1.9 pp—
6 months−10.1%+4.3%−14.4 pp—
Year to date−3.6%+7.5%−11.1 pp—
1 year+2.1%+9.9%−7.8 pp+7.2%
3 years+15.3%+49.8%−34.5 pp−5.5%
5 years−42.7%+42.8%−85.5 pp—
Max drawdown (1y)
−23.6%
18 Feb 2026 → 08 Oct 2026
Max drawdown (5y)
−58.7%
29 Nov 2021 → 25 Oct 2023
Compound annual growth (5y)
−10.5%
EURO STOXX 50 +7.4%

Price returns, dividends excluded.

Quarterly results

ESEF annual reports carry no quarters: the results are annual (below).

E/P over time

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Today's P/E sits at the 100 percentile of its own 2-quarter history (min 8.5, median 61.1, max 113.7; quarters with earnings only).

Fiscal years

Fiscal year20222023
Revenueunavailableunavailable
Revenue YoYunavailableunavailable
Net income331.8 m24.5 m
Net income YoYunavailable−92.6%
Diluted EPS8.710.56
Diluted EPS YoYunavailable−93.6%
net %unavailableunavailable
Free cash flowunavailableunavailable

Balance sheet & financial health

Fiscal year 2023 · 31 Dec 2023

Cash
18.3 m EUR
Financial debt
unavailable EUR
Net debt
unavailable EUR
Equity
3.6 bn EUR
Total assets
6.2 bn EUR
Debt / equity
unavailable
Current ratio
0.31x
ROE
0.7%
ROA
0.4%
FCF margin
unavailable

Financial statements (source on every figure)

Revenue and net income (EUR)

Income statement · EUR

Operating income
2022
297.2 m
2023
95.2 m

esef· 04 Apr 2024verified

Interest expense
2022
30.7 m
2023
45.0 m

esef· 04 Apr 2024verified

Pre-tax income
2022
386.4 m
2023
-3.1 m

esef· 04 Apr 2024verified

Net income
2022
331.8 m
2023
24.5 m

esef· 04 Apr 2024verified

Diluted EPS
2022
8.71
2023
0.56

esef· 04 Apr 2024verified

Dividend per share
2022
3.13
2023
2.65

esef· 04 Apr 2024derived

Balance sheet · EUR

Cash
2022
13.9 m
2023
18.3 m

esef· 04 Apr 2024verified

Current assets
2022
139.9 m
2023
127.3 m

esef· 04 Apr 2024verified

Goodwill
2022
143.7 m
2023
117.6 m

esef· 04 Apr 2024verified

Intangibles (excl. goodwill)
2022
1.9 m
2023
1.7 m

esef· 04 Apr 2024verified

Total assets
2022
6.1 bn
2023
6.2 bn

esef· 04 Apr 2024verified

Current liabilities
2022
532.2 m
2023
407.3 m

esef· 04 Apr 2024verified

Total liabilities
2022
2.8 bn
2023
2.6 bn

esef· 04 Apr 2024verified

Equity
2022
3.3 bn
2023
3.6 bn

esef· 04 Apr 2024verified

Shares outstanding at year end
2022
38.1 m
2023
43.8 m

esef· 04 Apr 2024derived

Cash flow · EUR

Operating cash flow
2022
218.6 m
2023
229.5 m

esef· 04 Apr 2024verified

Investing cash flow
2022
-683.4 m
2023
-258.8 m

esef· 04 Apr 2024verified

Financing cash flow
2022
463.4 m
2023
33.6 m

esef· 04 Apr 2024verified

Dividends paid
2022
119.1 m
2023
116.0 m

esef· 04 Apr 2024verified

Computed indicators

Growth

Revenue growth (YoY)
unavailable
input data missing
Revenue CAGR 3Y
unavailable
input data missing
Revenue CAGR 5Y
unavailable
input data missing
EBIT growth (YoY)
-68.0%
computed by olivLawFY 2023
Net income growth (YoY)
-92.6%
computed by olivLawFY 2023
Net income CAGR 3Y
unavailable
input data missing
Net income CAGR 5Y
unavailable
input data missing
EPS growth (YoY)
-93.6%
computed by olivLawFY 2023
EPS CAGR 3Y
unavailable
input data missing
EPS CAGR 5Y
unavailable
input data missing
FCF growth (YoY)
unavailable
input data missing

Profitability

Gross margin
unavailable
input data missing
EBITDA margin
unavailable
input data missing
EBIT margin
unavailable
input data missing
Net margin
unavailable
input data missing
FCF margin
unavailable
input data missing

Returns

ROE
0.7%
computed by olivLawFY 2023 · balance sheet at 31 Dec 2023
ROA
0.4%
computed by olivLawFY 2023 · balance sheet at 31 Dec 2023
ROIC
unavailable
input data missing
ROCE
1.7%
computed by olivLawFY 2023 · balance sheet at 31 Dec 2023
Payout ratio (EPS)
472.8%
computed by olivLawFY 2023
Payout ratio (FCF)
unavailable
input data missing

Balance sheet

Net debt
unavailable
input data missing
Net debt / EBITDA
unavailable
input data missing
Debt / equity
unavailable
input data missing
Interest coverage
2.1x
computed by olivLawFY 2023

Liquidity

Current ratio
0.3x
computed by olivLawbalance sheet at 31 Dec 2023
Quick ratio
unavailable
input data missing
Cash ratio
0.0x
computed by olivLawbalance sheet at 31 Dec 2023

Cash

Operating cash flow
229.5 m EUR
computed by olivLawFY 2023
Capital expenditure
unavailable
input data missing
Free cash flow
unavailable
input data missing
FCF conversion
unavailable
input data missing
Cash conversion
unavailable
input data missing

Efficiency

Days sales outstanding
unavailable
input data missing
Days inventory outstanding
unavailable
input data missing
Days payables outstanding
unavailable
input data missing
Cash conversion cycle
unavailable
input data missing

Market and valuation

Market capitalisation
2.9 bn EUR
computed by olivLawbalance sheet at 31 Dec 2023
Enterprise value
unavailable
input data missing
Market cap / net income TTM
116.3x
computed by olivLawFY 2023
P/E (TTM)
116.3x
computed by olivLawFY 2023
Earnings yield
0.9%
computed by olivLawFY 2023
P/B
0.8x
computed by olivLawbalance sheet at 31 Dec 2023
P/S
unavailable
input data missing
EV/EBITDA
unavailable
input data missing
EV/EBIT
unavailable
input data missing
EV/Sales
unavailable
input data missing
P/FCF
unavailable
input data missing
FCF yield
unavailable
input data missing
Dividend yield
4.1%
computed by olivLawFY 2023
Shareholder yield (distributions)
4.1%
computed by olivLawFY 2023 · balance sheet at 31 Dec 2023

1 indicators that do not apply to the sector.

Valuation

olivLaw classification

Insufficient data
What is missing
  • indicators available: 4 of at least 6
  • score weight coverage: 27.1% of at least 60%

A scoring methodology on indicators and valuation, not investment advice.

Closing price

65.10 EUR

05 Nov 2026Source: olivLaw, closing series

Market cap: 2.9 bn EUR

Key indicators

Market capitalisation
2.9 bn EUR
computed by olivLawbalance sheet at 31 Dec 2023
P/E (TTM)
116.3x
computed by olivLawFY 2023
P/B
0.8x
computed by olivLawbalance sheet at 31 Dec 2023
EV/EBITDA
unavailable
input data missing
ROE
0.7%
computed by olivLawFY 2023 · balance sheet at 31 Dec 2023
Net margin
unavailable
input data missing
Revenue growth (YoY)
unavailable
input data missing
Dividend yield
4.1%
computed by olivLawFY 2023

Coverage and freshness

19/37 reporting lines present
Latest full fiscal year: 2023
Latest reported period: 31 Dec 2023
Latest balance sheet date: 31 Dec 2023
Share count (cover of the latest filing), as of: 31 Dec 2023
Source: esefpublished 04 Apr 2024
verified 42derived 4

The data is older than the freshness threshold.

Score by group

27% · Insufficient data

Estimated value range

Low
21.00
EUR per share
Mid
24.86
EUR per share
High
31.08
EUR per share
Price: 65.10 EUR
The price is above the range
Potential to the central value: -61.8% (value / price − 1)
Margin of safety: -161.8% (1 − price / value)
Agreement between methods: low · 2 methods used · 2 independent bases

The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 5.99 – 49.10 EUR.

Valuation assumptions are editorial choices, not measured; beta is not measured.

Method ranges (EUR per share)

— — Mid · ▏ Price

Valuation methods

  • DCF (discounted cash flow)unavailable · input data missing
  • Peers: EV/EBITDAunavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
  • Peers: P/E5.99 – 13.06 (Mid 8.19)
    25 companies used · median multiple 14.6x · quartiles 10.7x – 23.3x
    ACKB.BR, AGS.BR, AZE.BR, BANI.BR, BAR.BR, BEKB.BR, BELYS.BR, BPOST.BR, CAMB.BR, CFEB.BR, COLR.BR, DECB.BR, DEME.BR, DIE.BR, ECONB.BR, ELI.BR, EVS.BR, FAGR.BR, FLOB.BR, FOU.BR, IBAB.BR, JEN.BR, KIN.BR, MELE.BR, MOUR.BR
  • Dividend discount (DDM)36.00 – 49.10 (Mid 41.54)

Assumptions (illustrative, editorial)

Risk-free rate
3.0%
Equity risk premium
5.5%
Beta (default)
1.00
Cost of equity
8.5%
Terminal growth
2.0%

Factor scorecard

Insufficient data

Minimum-evidence gate: indicators available: 4 of at least 6; score weight coverage: 27.1% of at least 60%

FactorValueScoreWeight used
ROIC · Qualityunavailableunavailable—
Net margin · Qualityunavailableunavailable—
FCF conversion · Qualityunavailableunavailable—
Revenue CAGR 3Y · Growthunavailableunavailable—
EPS CAGR 3Y · Growthunavailableunavailable—
Net debt / EBITDA · Balance sheetunavailableunavailable—
Interest coverage · Balance sheet2.1x9 (on a fixed band)23%
Current ratio · Balance sheet0.3x0 (on a fixed band)15%
P/E (TTM) · Valuation116.3x4 (vs peers)38%
EV/EBITDA · Valuationunavailableunavailable—
FCF yield · Valuationunavailableunavailable—
Shareholder yield (distributions) · Returns4.1%58 (on a fixed band)23%
Payout ratio (FCF) · Returnsunavailableunavailable—

Factors without a value were dropped; the remaining weights were renormalised.

Score groups

  • Balance sheet6/100 · 2/3 factors with a value
  • Growth· partialunavailable · 0/2 factors with a value
  • Quality· partialunavailable · 0/3 factors with a value
  • Returns· partial58/100 · 1/2 factors with a value
  • Valuation· partial4/100 · 1/3 factors with a value

A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.

Memo

AEDIFICA (AED.BR). Latest full fiscal year: 2023; data up to 2023-12-31.

Figures computed from the financial statements: ROE 0.7%.

The estimated value range is 21.00–31.08 EUR per share (median of 2 methods, agreement: low); assumptions are illustrative. Against the central value of 24.86 EUR, the price of 65.10 EUR leaves a potential of -61.8% (value / price − 1) and a margin of safety of -161.8% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.

Insufficient data for a verdict (indicators available: 4 of at least 6; score weight coverage: 27.1% of at least 60%).

Text generated deterministically from the figures shown; no language model. Not investment advice.

What supports the thesis

No signal among the computed factors. That is not an absence of risk: factors without data were not assessed, and business risks (margins, inventory, demand) are in the source-based analysis.

What contradicts it

  • Interest coverage: 2.1x
  • Current ratio: 0.3x
  • P/E (TTM): 116.2x
  • The price is above the estimated value range
  • The valuation methods diverge

Not assessed (insufficient data or a ratio without meaning): ROIC, Net margin, FCF conversion, Revenue CAGR 3Y, EPS CAGR 3Y, Net debt / EBITDA, EV/EBITDA, FCF yield, Payout ratio (FCF).

Versus the vertical median

Listed companies from Belgium · same country · compared with 40 companies

Multiples and returns vs the median

P/E
116.3x
vertical median 16.7x
above median (+597.8%)
EV/EBITDA
—
vertical median 5.2x
P/S
—
vertical median 1.1x
P/B
0.8x
vertical median 1.2x
below median (−34.5%)
ROE
0.7%
vertical median 8.3%
below median (−91.4%)
Net margin
—
vertical median 4.0%
EBIT margin
—
vertical median 8.2%
Revenue YoY
—
vertical median 0.5%
Net debt/EBITDA
—
vertical median 0.5x
Dividend yield
4.1%
vertical median 1.8%
above median (+120.9%)

Companies in the vertical

Market capP/EROENet marginRevenue YoY1A / 3A
ELI.BRElia Group11.9 bn23.39.6%13.6%−2.0%+28% / +34%
LOTB.BRLotus Bakeries11.4 bn66.420.9%12.7%+10.0%+82% / +76%
GBLB.BRGroupe Bruxelles Lambert - Groep Brussel Lambert10.6 bn82.40.8%2.1%+1.0%+6% / +9%
DIE.BRD'ieteren Group9.7 bn23.2—5.3%−1.5%+22% / +16%
ACKB.BRAckermans & Van Haaren8.8 bn22.28.4%7.6%+18.6%+22% / +77%
COLR.BRColruyt Group4.4 bn14.69.4%2.9%+3.1%+12% / −6%
DEME.BRDeme Group4.2 bn12.215.5%8.3%+1.3%+21% / +72%
AZE.BRAzelis Group2.9 bn16.16.6%4.3%+1.5%+29% / −42%
MELE.BRMelexis2.1 bn12.430.7%18.4%−3.3%−1% / −38%
BEKB.BRNV Bekaert SA2.1 bn30.73.1%1.8%−6.4%+10% / −5%
FAGR.BRFagron1.8 bn22.216.7%9.2%+14.3%+15% / +40%
KIN.BRKinepolis Group1.4 bn33.919.3%7.0%−4.5%+62% / +11%
JEN.BRJensen Group706.9 m17.215.1%9.1%+13.3%+28% / +111%
BAR.BRBarco563.5 m9.17.9%6.7%−9.9%−48% / −59%
IBAB.BRIon Beam Applications487.2 m39.510.7%2.1%+24.5%+48% / +52%
DECB.BRDeceuninck341.3 m24.64.3%1.7%−4.5%+8% / +8%
CAMB.BRCampine272.3 m12.228.6%6.1%+13.4%−12% / +161%
CFEB.BRAannemingsmaatschappij Cfe266.8 m11.19.9%2.0%−5.3%+22% / +48%
MOUR.BRMoury Construct261.2 m10.721.3%13.1%−4.0%+11% / +76%
EVS.BREvs Broadcast Equipment245.9 m6.020.8%21.7%+14.3%−49% / −36%
BPOST.BRBpost229.8 m3.56.3%1.5%−2.6%−39% / −75%
ECONB.BREconocom Group210.7 m40.51.2%0.2%+4.3%−1% / −36%
IMMO.BRImmobel172.2 m—-7.4%-25.2%−32.8%−24% / −36%
MONNI.BRKeyware Technologies171.0 m162.03.5%4.5%−5.9%−5% / −17%
HYSG.BRHybrid Software Group PLC121.3 m—-2.5%-5.5%+7.2%−4% / +13%

1- and 3-year price returns: for AED.BR from daily closes (the same as the performance table), for the other companies from month-end closes.

olivLaw engine forecast

The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

The engine has no published run for this company yet.

Valuation scenarios (editable assumptions)

Illustrative scenarios

Scenarios are not available. input data missing

AI analysis

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

In brief

Aedifica is a Belgian investor in healthcare real estate, with a portfolio of 617 care sites in eight European countries, operated by more than 140 operator groups. The company remains relevant because of structural demand created by an ageing population, though higher financing costs and slower transaction markets in 2023 were a challenge 1.

SWOT

Strengths

  • Large portfolio diversified across several European countries, with many sites and a high share of private tenants 1.
  • Triple net contracts in many countries, which shift most operating costs to operators 1.
  • Broad energy certification of the portfolio and a clear plan to reduce energy intensity up to 2030 1.

Weaknesses

  • Dependence on a few large operators whose financial difficulties could affect rent collection 1.
  • Exposure to older buildings in some markets that may need investment to meet new standards 1.
  • Small operating structure that leaves day-to-day running to operators and limits direct control over service quality 1.

Opportunities

  • Structural demand for residential care, supported by an ageing population, could allow portfolio growth through acquisitions 1.
  • Markets with a high share of privately financed care could offer new investment opportunities 1.
  • Sustainability requirements may favour energy-efficient assets, which could attract green financing 1.

Threats

  • Higher financing costs could make acquisitions harder and reduce the appeal of property investment 1.
  • Operator difficulties caused by staff shortages and energy costs could raise the risk of rent default 1.
  • Changes in regulation and public care funding could alter market conditions in the portfolio's countries 1.

Risks

  • Tenant concentrationhigh

    A limited number of operator groups generate a significant share of contractual rent. Difficulties at one of them could directly affect the company's revenue 1.

  • Climate riskmedium

    Climate change may raise temperatures inside buildings and bring flooding, which could require costly asset adaptations 1.

  • Cost of financingmedium

    High interest rates could reduce asset values and slow acquisitions, affecting the company's growth 1.

  • Energy compliancemedium

    Stricter energy performance requirements could force additional investment in older buildings if sufficient renovations cannot be carried out 1.

  • Sector staff shortageslow

    A shortage of qualified care staff can affect operator activity and the stability of long-term rents 1.

Investment thesis

What would need to be true (bull case)

  • If demand for residential care keeps growing with the ageing population, the existing portfolio could generate stable long-term rental income 1.
  • The contract structure, in which operators bear many costs, could protect the company's margins if the market remains stable 1.
  • If financing becomes more accessible, acquisitions could speed up portfolio growth compared with the level seen in 2023 1.

What would break the thesis

  • If major operators run into financial difficulty, rents could fall and income could be lost from the affected sites 1.
  • Higher financing costs could reduce asset values and make new investments less attractive 1.
  • Adapting buildings to energy and climate standards could require significant spending, which could reduce returns 1.

What to watch

  • Development of contractual rents and operator occupancy rates2024
  • Pace of acquisitions and transactions in key markets2024
  • Progress towards the 130 kWh/m² target by 20302030
  • Publication of the Environmental Data Report for 2023June 2024

Products, market & competition

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

The business

Aedifica owns and leases healthcare buildings, mainly residential care homes for older people, but also senior housing, childcare centres, mixed-use care buildings and other care facilities. At 31 December 2023 the fair value of its real estate investments was 5.679.565.002 € 1, and the portfolio had a total area of 2.193.002 m² 1. Most contracts are triple net, so the operator generally bears operating costs, maintenance and the risk of rent default, which means the gross yield is generally close to the net yield 1.

Revenue comes from contractual rent paid by operators, which at 31 December 2023 amounted to 325.213.490 € 1. The average gross yield was 5,8% 1, while properties in Germany, Finland and Sweden are often double net, with some costs borne by the owner 1. The company relies on a few large operator groups, but most tenants are private, which reduces dependence on a single type of public funding 1.

Aedifica has a small operating structure with 127 employees 1 and focuses on acquisitions, development and portfolio management rather than direct operation of the sites. Sustainability targets include reducing the portfolio's energy intensity to 130 kWh/m² by 2030, compared with 167 kWh/m² in 2022 1.

Segments

Residential care homes for older people

Residential care homes are the main segment, accounting for 67% of the portfolio's real value 1. They provide permanent residence with collective services, help with daily life and nursing or paramedical care 1.

Senior housing and mixed-use care buildings

Senior housing, at 4% of real value, and mixed-use care buildings, at 16%, combine individual apartments with on-demand services or several care functions on one site 1. These assets could help the company diversify the types of care it offers 1.

Childcare centres and other care buildings

Childcare centres represent 6% of real value and other care buildings 7% 1. Exposure to this segment is smaller, but it offers diversification towards other social and medical service categories 1.

Market context

Elderly care markets in Western and Northern Europe are supported by a growing number of people over 80, and the source points to strong demand against limited supply of space 1. However, higher energy costs, staff shortages and stricter regulation have made financing harder for operators and lengthened transaction processes 1. This dynamic could slow acquisitions if financing remains expensive.

In many countries a large part of care funding comes from public sources, but the privately paid share has risen in recent years, especially in the United Kingdom 1. This can support demand for private places, but it exposes operators to pressure from social budgets and policy changes 1.

Trends

  • Ageing populationtailwind

    The share of people over 80 is rising in several European countries, and the source links this trend to sustained demand for residential care 1. If supply stays limited, the position of existing sites could be strengthened.

  • Energy and staffing costsheadwind

    Rising energy costs and staff shortages weigh on operator margins and can raise the risk of rent default 1. Aedifica is trying to reduce consumption through energy efficiency and EPC certificates, but the impact could persist 1.

  • More expensive financingheadwind

    Higher interest rates reduced the number of transactions in 2023 in several markets, which could slow growth through acquisitions 1. The effect on yields depends on how the cost of capital evolves 1.

  • Regulation and sustainabilitymixed

    European requirements on energy performance and the EU taxonomy are becoming more important for buildings 1. They can create adaptation costs, but also opportunities for energy-efficient assets 1.

Competitive position

The care investment market includes specialised real estate investors and funds competing for the same quality assets, especially in the top segment. The source indicates that investors are highly selective about building quality and location, and the top segment is seen as a relatively safe haven 1. Competition for well-located assets could push up acquisition prices.

On the operator side, competition comes from large groups that manage many sites and can negotiate their contract terms. The company depends in part on a few such groups, so their performance matters considerably 1.

  • Clariane

    Major care operator and one of Aedifica's largest tenants, present in several countries of the portfolio 1.

  • Colisée

    Care operator present among the company's main tenants, with a significant share of revenue 1.

  • Orpea

    Care operator that appears in the Aedifica portfolio and whose share of rent declined in 2023 1.

  • Vivalto

    Care operator group active in some of the countries where Aedifica holds assets 1.

News & filings

In the press

No news in our archive over the last 180 days.

Annual reports (ESEF)

Sources

  1. [1] Annual report, fiscal year ended 2023-12-31 (ESEF) · SEC / Aedifica · 31 Dec 2023

Figures computed by olivLaw from ESEF annual reports and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.